Cargando…
Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417070/ https://www.ncbi.nlm.nih.gov/pubmed/36028758 http://dx.doi.org/10.1038/s41409-022-01795-3 |
_version_ | 1784776622873772032 |
---|---|
author | Uyemura, Bradley S. Abid, Muhammad Abbas Suelzer, Elizabeth Abid, Muhammad Bilal |
author_facet | Uyemura, Bradley S. Abid, Muhammad Abbas Suelzer, Elizabeth Abid, Muhammad Bilal |
author_sort | Uyemura, Bradley S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9417070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-94170702022-08-30 Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen Uyemura, Bradley S. Abid, Muhammad Abbas Suelzer, Elizabeth Abid, Muhammad Bilal Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-08-26 2022 /pmc/articles/PMC9417070/ /pubmed/36028758 http://dx.doi.org/10.1038/s41409-022-01795-3 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Correspondence Uyemura, Bradley S. Abid, Muhammad Abbas Suelzer, Elizabeth Abid, Muhammad Bilal Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen |
title | Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen |
title_full | Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen |
title_fullStr | Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen |
title_full_unstemmed | Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen |
title_short | Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen |
title_sort | efficacy of sars-cov-2 primary and booster vaccine doses in car-t recipients – targeting the target antigen |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417070/ https://www.ncbi.nlm.nih.gov/pubmed/36028758 http://dx.doi.org/10.1038/s41409-022-01795-3 |
work_keys_str_mv | AT uyemurabradleys efficacyofsarscov2primaryandboostervaccinedosesincartrecipientstargetingthetargetantigen AT abidmuhammadabbas efficacyofsarscov2primaryandboostervaccinedosesincartrecipientstargetingthetargetantigen AT suelzerelizabeth efficacyofsarscov2primaryandboostervaccinedosesincartrecipientstargetingthetargetantigen AT abidmuhammadbilal efficacyofsarscov2primaryandboostervaccinedosesincartrecipientstargetingthetargetantigen |